(VIANEWS) – The NASDAQ opens in less than six hours and Xenetic Biosciences‘s pre-market value is already 5% up.
Xenetic Biosciences’s last close was $0.63, 49.28% under its 52-week high of $1.25.
The last session, NASDAQ finished with Xenetic Biosciences (XBIO) rising 3.93% to $0.63. NASDAQ fell 1.68% to $11,910.52, following the last session’s downward trend on what was an all-around down trend trading session.
About Xenetic Biosciences
Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing XCART, a personalized chimeric antigen receptor T cell (CAR T) platform technology engineered to target patient-specific tumor neoantigens. The company engages in the discovery, research, and development of biologic drugs and oncology therapeutics. It advances cell-based therapeutics targeting the B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. It is also leveraging PolyXen, its proprietary drug delivery platform, by partnering with biotechnology and pharmaceutical companies. It has collaboration agreements with Takeda Pharmaceutical Co. Ltd., Serum Institute of India Limited, PJSC Pharmsynthez, and SynBio LLC. Xenetic Biosciences, Inc. is headquartered in Framingham, Massachusetts.
Earnings Per Share
As for profitability, Xenetic Biosciences has a trailing twelve months EPS of $-1.704.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -59.34%.
Moving Average
Xenetic Biosciences’s worth is way above its 50-day moving average of $0.40 and below its 200-day moving average of $0.64.
Yearly Top and Bottom Value
Xenetic Biosciences’s stock is valued at $0.63 at 04:27 EST, way under its 52-week high of $1.25 and way higher than its 52-week low of $0.24.
Sales Growth
Xenetic Biosciences’s sales growth for the next quarter is negative 27.9%.
Volume
Today’s last reported volume for Xenetic Biosciences is 50649 which is 36.89% below its average volume of 76114.
More news about Xenetic Biosciences (XBIO).
